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Summary 
Human life expectancy is influenced not only by longevity assurance mechanisms and 
disease susceptibility loci but also by the environment, gene-environment interactions, 
and chance. MicroRNAs (miRNAs) are a class of small noncoding RNAs closely related 
to genes. Circulating microRNAs have been shown as promising non-invasive 
biomarkers in the development of many pathophysiological conditions. However, the 
concentration of miRNA in the circulation may also be affected by environmental 
factors. We used a next-generation sequencing platform to assess the association of 
circulating miRNA with life expectancy, for which deaths are due to all causes 
independent of genes. In addition, we showed that miRNAs are present in 41-year 
archived plasma samples, which may be useful for both life expectancy and all-cause 
mortality risk assessment. Plasma miRNAs from nine identical male twins were profiled 
using next-generation sequencing. The average absolute difference in the minimum life 
expectancy was 9.68 years. Intra-class correlation coefficients were above 0.4 for 50% 
of miRNAs. Comparing deceased twins with their alive co-twin brothers, the 
concentrations were increased for 34 but decreased for 30 miRNAs. Identical twins 
discordant in life expectancy were unlike in the majority of miRNAs, suggesting that 
environmental factors are pivotal in miRNAs related to life expectancy. 
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INTRODUCTION 
Human life expectancy is influenced not only by longevity assurance mechanisms and 
disease susceptibility loci but also by the environment, gene-environment interactions, 
and chance (Brooks-Wilson, 2013; Cournil & Kirkwood, 2001). A recent laboratory 
experiment has discovered that microRNAs (miRNAs) regulate lifespan of the nematode 
Caenorhabditis elegans, suggesting that miRNAs play a role in life expectancy (Smith-
Vikos & Slack, 2012). MiRNAs are a class of small (18-24 nucleotides) noncoding RNAs 
that can induce gene silencing by targeting mRNA either by translational repression or 
mRNA cleavage (Lau & Lai, 2005; Matzke & Birchler, 2005).  The most intriguing 
feature of miRNAs is their unusual stability in the extracellular environment. For 
example, circulating miRNAs are stable through multiple freeze-thawing cycles 
(Fichtlscherer, Zeiher and et al., 2011), RNase-mediated degradation (Fichtlscherer, 
Zeiher and et al., 2011), extreme pH conditions, high temperatures and prolonged 
storage (van Empel, De Windt and et al., 2012). The concentration of miRNAs are 
measurable with a greater sensitivity than proteins (Su, Han and et al., 2011). 
Circulating miRNAs have been shown as promising biomarkers in the development of 
cardiovascular disorders (Su, Han and et al., 2011; Zampetaki, Willeit and et al., 2012), 
cancers (Grady & Tewari, 2010; He, Lin and et al., 2015) and other pathophysiological 
conditions.  Studies have shown that extracellular miRNAs can be taken up by cells and 
affect target gene expression profile in the recipient cells (Fichtlscherer, Zeiher and et 
al., 2011). Peripheral blood samples are easy to obtain with little risk to individuals 
compared to biopsies and surgical procedures. Therefore, we thought that circulating 
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miRNAs could be promising less-invasive biomarkers for understanding of the life 
expectancy.  
Genetic makeup can affect phenotypes including longevity and disease susceptibility 
loci (Brooks-Wilson, 2013; Cournil & Kirkwood, 2001), and the expression of miRNAs 
(Geeleher, Huang and et al., 2012). A previous study of 56 trios from the HapMap 
project showed that genetic factors affect 124 miRNAs in lymphoblastoid cell lines with 
an average heritability of 30% (Geeleher, Huang and et al., 2012).  Identical twins are 
ideally a natural setting to control for germline (including genes and inherited epigenetic 
modifications) that cannot be controlled for in the traditional singleton population study. 
As identical twins share 100% genetic materials, any difference in miRNA in the 
circulation between co-twins might be caused by environmental factors such as diet 
(Ryu, Langkamp-Henken and et al., 2011) and exercise (Gomes, Kim and et al., 
2015).Therefore, understanding of plasma miRNA composition that is free of germline 
influence is pivotal to assess environmental effects on the spectrum of circulating 
miRNAs.  In this study, we first showed that miRNAs present in long-term archived 
plasma samples were measurable with a next-generation sequencing platform, and 
then we assessed the association of circulating miRNA with life expectancy, for which 
deaths are due to all causes.  
 
MATERIALS AND METHODS 
Subjects  
Running head: MicroRNAs and life expectancy 
5 
 
The National Heart, Lung, and Blood Institute (NHLBI) Twin Study has been widely 
described (Dai, Krasnow and et al., 2013; Reed, Carmelli and et al., 1993; The 
U.S.National Heart Lung and Blood Institute (NHLBI)., 2005). The NHLBI Twin Study 
was designed to prospectively investigate the genetic and environmental role in 
cardiovascular risk through inclusion of 514 middle-aged, white male, veteran twin pairs 
born between 1917 and 1927 at baseline (1969-1973) (Dai, Krasnow and et al., 2013; 
Reed, Carmelli and et al., 1993). Based on zygosity ascertained by 8 red blood cell 
antigen groups (serotyping 22 erythrocyte antigens) in the 1960s and variable number 
of tandem repeat DNA markers in the 1980s (Reed, Carmelli and et al., 1993), the 
baseline parent cohort included 253 monozygotic (MZ) and 261 dizygotic twin pairs 
(Reed, Carmelli and et al., 1993). The reported study was approved by the Institutional 
Review Boards of Vanderbilt University. 
 
At baseline, blood was drawn from the forearm vein after an overnight fast into EDTA 
tubes and immediately placed on ice. After centrifugation, plasma aliquots were frozen 
at -70 °C (Dai, Krasnow and et al., 2013; Mikulec, Holloway and et al., 2004; Reed, 
Tracy and et al., 1994). In this exploratory study, the inclusion criteria were identical twin 
pairs in which co-twins were discordant for age at death (excluding accidental causes), 
had a minimum difference in age at death of at least 5 years, and had available baseline 
plasma samples that were collected 41 years ago. We originally included 5 discordant 
MZ twin pairs. As one plasma sample yielded an insufficient amount of RNA, we 
present data from 9 twin subjects (four discordant MZ pairs and one unpaired twin) in 
this report.  
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Assessment of endpoints  
We previously described the assessment of endpoints (Dai, Krasnow and et al., 2013; 
Wu, Neale and et al., 2014). Vital status as well as the cause and date of death through 
December 31, 2010 were ascertained from medical records and death certificates in 
four follow-up examinations (exam 2, 1981-1982; exam 3, 1986-1987; exam 4, 1995-
1997; and exam 5, 1999-2000), and through death certificates or the National Death 
Index after exam 5 (Mikulec, Holloway and et al., 2004). Criteria used for ascertaining 
outcomes in four follow-up examinations were standardized, and a panel of 
investigators made decisions regarding disease diagnosis: at examinations 2 and 3 two 
independent physicians reviewed medical records; at examinations 4 and 5 one 
physician reviewed medical records. Physicians assigned corresponding International 
Classification of Diseases Ninth Revision codes. Death certificates or the National Death 
Index with the Ninth Revision codes was obtained for decedents. The endpoint was 
death from all causes. Twins were considered lost to follow-up if a death certificate or 
coding from the National Death Index could not be traced.  
miRNA profiling using next-generation sequencing (NGS) 
Blood was drawn from the forearm vein after an overnight fast into EDTA tubes and 
immediately placed on ice. After centrifugation, plasma aliquots were frozen at -70 °C 
(Mikulec, Holloway and et al., 2004; Reed, Tracy and et al., 1994). We performed 
miRNA profiling using NGS at the Vanderbilt Center for Genomic Research. The 
sequencing libraries were constructed using the New England Biolabs (NEB) small RNA 
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sequencing kit and were analyzed on an Illumina HiSeq 2000 platform with single end 
50 nucleotide read length.  Post sequencing data analysis was performed with an in-
house small RNA sequence analysis pipeline as described (Wang, Li and et al., 2012). 
The miRNA mapping results were normalized with reads per million then log2 
transformed before statistical analysis. The data was deposited in the GEO database 
with an accession number "GSE80730". 
 
Statistical analysis 
All mapped reads were normalized to reads per million then converted to log 2 values. If 
a log 2 value of a miRNA was above the average value of all miRNAs, we defined this 
miRNA as detectable.  A detectable miRNA that was present in at least 70% of samples 
analyzed was defined as “present miRNA” in the sample set. A total of 167 present 
miRNAs were observed from the primary analyses. The miRNA levels were compared 
by the paired t-test. 
For surviving twins, we calculated the minimum life expectancy as age at the last 
follow up date. For deceased twins, we calculated the life expectancy using age at 
death. As all twin pairs were discordant for vital status (i.e. one co-twin was deceased 
and his co-twin was still alive), we compared the minimum life expectancy for surviving 
twins with the life expectancy of deceased twins.   
Intraclass correlation coefficient (ICC) was calculated to estimate the similarity of 
the measurement between the co-twins in a twin pair. ICC values greater than 0.75 
represent “excellent similarity” in miRNAs between co-twins and values between 0.4 
and 0.75 represent “fair to good similarity” (Lexell & Downham, 2005). Fold changes 
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were the ratio of log2 transformed normalized read counts of deceased twins to their 
alive co-twins. Using a 2-fold expression difference as a cutoff point for dysregulated 
miRNAs (SGC, 2004).  We only showed miRNAs present in at least 70% of samples to 
determine the concentration variation of miRNAs. The between-subject variation of the 
coefficient (CV) for each miRNA was estimated to quantify the concentration variation 
among the 9 studied subjects.  
 
A P value below 0.05 was considered significant without control for multiple testing. The 
Bonferroni corrected significance level of alpha that controlled multiple testing was  
0.0003 as 167 miRNAs were tested (Dunn, 1961). All statistical tests were two-sided 
and were performed using SAS statistical software, version 9.3 (SAS Institute, Cary, 
NC). 
 
RESULTS 
Participants  
The twins were middle-aged at baseline with an average age of 46 years and ranged 
from 44 to 51 years. The characteristics of the twins are shown in Table 1. Baseline 
plasma samples were collected 41 years ago. During the 41-year follow-up for all-cause 
mortality in each of the four pairs studied, one co-twin was deceased (Figure 1). The 
average years of follow-up to death was 32.5. The average life for deceased twins was 
74.8 years and the minimum life expectancy for the still alive twins was 81.4 years. The 
sole unpaired twin died at the age of 77.5 (Table 1). The average absolute difference in 
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the minimum life expectancy between age at the last follow-up date of alive co-twins 
and the age at death of their co-twins was 9.68 years (SD 2.24 years). Since identical 
co-twins differed in life expectancy, environmental factors must be pivotal factors 
affecting the life expectancy. 
Detectability and presence of plasma miRNA   
The number of detectable miRNAs for each individual is shown in Figure 2. A total of 
866 miRNAs were detected in the 41-year old plasma collected from nine twins (709 
miRNAs in deceased twins and 781 miRNAs in living twins); 276 miRNAs were detected 
only in one individual. Of the 866 miRNAs, 167 miRNAs were observed in at least of 
70% samples and were defined as “present miRNAs” in the sample set. 
ICC: the similarity of the measurement between the co-twins in one twin pair 
Table 2 shows the ICCs of miRNAs present in at least 70% of samples between co-twin 
brothers. ICCs for 47% of miRNAs were in the category of “excellent similarity” or “fair to 
good similarity between co-twins”. ICCs for the remaining 53% of miRNAs were not 
similar (ICC <0.4). About 4% of the miRNAs have ICCs that are greater than 0.75, 
which indicate excellent similarity between co-twins for those miRNAs; about 43% of 
miRNAs have ICCs between 0.4 and 0.75, indicating a fair to good similarity.  
Concentration difference between deceased twins and alive co-twin brothers  
Using a 2-fold change as a cutoff point, we identified 34 (20%) miRNAs with increased 
concentrations and 30 (18%) miRNAs with decreased concentration in alive co-twins 
compared to deceased twin brothers (Table 2). 
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Among the 4 twin pairs that were discordant for life expectancy, at alpha 0.05, the 
concentrations of hsa-miR-3615 and hsa-miR-619 that were present in at least 70% of 
the plasma samples were significantly higher in deceased twins than living twins in the 
primary analysis. The concentration of hsa-miR-423-5p and hsa-miR-4305 detectable in 
less than 70% of the plasma samples were significantly higher in deceased twins than 
alive twins in a secondary analysis. However, none of miRNAs were statistically 
significant after multiple-testing adjustment. Table 3 shows the top 20 miRNAs with the 
smallest p-value for differences in miRNA levels between long-lived and short-lived co-
twins for both miRNAs present in  at least 70% and <70% of plasma samples 
respectively (Table 3).    
Among the 34 miRNAs having higher concentrations that were present in at least 70% 
of samples, 29% had between-subject CVs less than 10%, 6% had between-subject 
CVs ranging in 10-15%, 3% in 15-20%and 62% had between-subject CVs of at least 
50%. Among the 30 miRNAs showing lower concentration in alive twins, 53% had 
between-subject CVs less than 10%, 7% varying in 10-15%, 3% in 15-20%, 7% in 20-
30% and 30% had between-subject CVs of at least 50% (Table 2).  
Abundance of miRNAs 
The five miRNAs having highest concentrations in the samples were miR-1224, miR-
518d-3p, miR-518a-3p, miR-320 and miR-4532 (Figure 3). The sum of read counts 
from these five miRNAs accounted for 23.9% of the total number of all miRNAs present 
in the samples. Of the top five miRNAs, miR-4532 had the highest average level.  
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DISCUSSION 
This study detected 866 miRNAs among the plasma samples that were collected 41 
years ago from nine male monozygotic twins. Comparing deceased twins with their 
living co-twin brothers, 34 miRNAs had higher concentrations and 30 miRNAs had lower 
concentration in deceased twins.  Among the miRNAs showing concentration 
differences, 40.4% had between-subject CVs less than 20% for miRNAs which 
concentration were higher in deceased twins and 55.6% had CVs less than 20% for 
miRNAs which concentration were lower in deceased twins .  
This is the first report to profile plasma miRNAs in relation to all-cause mortality 
by next generation sequencing. Circulating miRNAs have been shown as promising 
non-invasive markers in various pathological conditions including cardiovascular 
disorders (Su, Han and et al., 2011; Zampetaki, Willeit and et al., 2012) and cancers 
(Grady & Tewari, 2010) which were the two top causes of death in the United States 
(Yoon, Bastian and et al., 2014). Previous studies have reported the characterization of 
miRNA spectrum in plasma, serum, and whole blood by NGS (Moldovan, Batte and et 
al., 2014). For example, using NGS to profile plasma miRNAs, one study found that low 
plasma concentrations of miR-483-5p and miR-103 had better prognosis while low 
plasma miR-29a and let-7c concentrations had poorer prognosis for 5-year survival 
than those with high concentrations for Chinese patients with nasopharyngeal 
carcinoma (Wang, Yan and et al., 2014). It is interesting that the current study also 
found the miR-483-5p, miR-103a and miR-103b concentrations in plasma were 
inversely associated with all-cause mortality in male monozygotic twins. A study from 
the US found that serum miR-146b, miR-221, miR-155, miR-17-5p, miR-27a and miR-
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106a concentrations were significantly reduced in lung cancer patients using real-time 
PCR (Heegaard, West-Norager and et al., 2012). Consistently, our study also found that 
miR-27a was inversely associated with all-cause mortality.  Although the design and 
subjects for these two studies are different, the consistent results may be useful for all-
cause mortality risk detection.  
Monozygotic twins are an ideal natural setting to control for germline contribution 
(including genes and inherited epigenetic modifications) that otherwise cannot be 
controlled for in traditional population studies. As monozygotic twins share 100% of their 
germline, any difference in miRNA levels between co-twins most likely are caused by 
environmental factors. Therefore, characterizing the spectrum of circulating miRNA free 
of germline influence is pivotal to understanding the influence of environmental factors 
on miRNAs in circulation. Changing environmental factors are more feasible to alter 
compared to genomic sequence. The identification of some miRNA concentration 
differences associated with all cause of mortality in our twin study encourages the 
exploration of the possible association of specific miRNAs in circulation related to all-
cause mortality, which in turn would help clinicians to identify individuals that may have 
a higher risk for death. This information may assist public health professionals to assess 
possible interventions.   
One limitation of our study is that our results were not validated by RT-qPCR. If 
any method could be considered a single gold standard among miR detection 
techniques, it would be RT-qPCR as it offers a good balance between cost, precision, 
and sample size along with a large functional dynamic range. It is used to validate 
results from whole-genome screening methods, such as NGS, and in the screening of 
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clinically relevant subsets of miRs (Hunt, Broyles and et al., 2015). However, the NGS 
method is not constrained to previously reported miR sequences logged in miRBase (as 
is the case with RT-qPCR), and although this means novel miR sequences may be 
discovered, not every small RNA read obtained will be a functional miR. 
Our study has a number of interesting findings. The NGS technology is not 
hindered by variability in melting temperatures, co-expression of nearly identical miRNA 
family members, or post-transcriptional modifications (Git, Dvinge and et al., 2010). 
NGS is ideal for the identification of novel miRNAs, and provides unprecedented 
quantitative and qualitative accuracy. However, recent findings as well as our own study 
indicate different profiling methods, for example qPCR vs. NGS or even a different 
library construction method will generate different miRNA profiles (Raabe, Tang and et 
al., 2014). Therefore, one needs to be cautious when compare results from different 
studies.  Plasma samples used in our study have been stored for 41 years. Globally it is 
not common to have more than 30-year old plasma samples from identical twins. These 
samples are extremely precious, limited, and non-replaceable. However, other 
limitations in our study need to be acknowledged. Our twins were Caucasian males, 
thus our results may not be generalized to women and other ethnic groups. Our study 
was not able to collect plasma from more twins and from dizygotic twins. Further study 
with a larger sample size is warranted. We could not completely rule out the possibility 
of residual confounding.  
In conclusion, this exploratory study provides information on circulating miRNAs that 
may be related to life expectancy and all-cause mortality. This finding might provide 
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clinicians and public health professionals with additional information to identify an 
individual with higher risk for death, and facilitate the decision on the use of appropriate 
intervention methods.  In addition, our study also suggests non-genetic factors might 
have stronger influence on miRNAs related to life expectancy compared with genetic 
factors.
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Table 1. Characteristics of nine monozygotic twins  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*0=alive, 1=deceased 
 
 
 
 
Pair  ID Vital Status* Follow-Up 
Years 
Baseline Age
(years) 
Age at death or last 
follow-up date (years) 
P0001  V0001 1 32.5 45 77.5 
P0002  V0002 0 37.4 45 82.4 
P0002  V0004 1 25.5 45 70.5 
P0003  V0005 0 37.4 44 81.4 
P0003  V0006 1 30.8 44 74.8 
P0004  V0007 0 37.2 51 88.2 
P0004  V0008 1 26.7 51 77.7 
P0005  V0009 0 37.2 46 83.2 
P0005  V0010 1 27.5 46 73.5 
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Table 2. Fold change, ICC, between-subject CV of plasma miRNAs presented in at least 70% samples from nine 
monozygotic twins  
MiRNA Fold change†  ICC‡ CV 
 Detectable in all samples (n=78)
hsa-miR-4306 2.46¶  -0.20 9.59% 
hsa-miR-425 2.25¶  -0.67 15.32% 
hsa-miR-4290 1.92  -0.14 10.11% 
hsa-miR-2861 1.85  -0.23 7.38% 
hsa-miR-3928 1.82  -0.12 11.26% 
hsa-miR-3960 1.76  -0.84 9.85% 
hsa-miR-3648 1.66  -0.19 6.67% 
hsa-miR-4419a 1.63  0.77 9.15% 
hsa-miR-3181 1.54  0.12 9.26% 
hsa-miR-619 1.53  0.58 7.58% 
hsa-miR-1292 1.46  0.26 9.73% 
hsa-miR-940 1.46  -0.06 11.91% 
hsa-miR-203 1.42  -0.08 6.09% 
hsa-miR-671 1.40  0.36 7.29% 
hsa-miR-1273 1.38  0.52 8.45% 
hsa-miR-185 1.36  0.43 7.76% 
hsa-miR-4511 1.36  0.89 10.18% 
hsa-miR-3175 1.35  0.14 10.61% 
hsa-miR-3192 1.33  0.55 9.66% 
hsa-miR-518e 1.31  -0.52 13.53% 
hsa-miR-762 1.28  -0.46 8.67% 
hsa-miR-1469 1.25  -0.62 19.52% 
hsa-miR-4651 1.24  0.12 7.21% 
hsa-miR-3127 1.20  -0.52 7.21% 
hsa-miR-370 1.20  0.97 6.64% 
hsa-miR-3180-5 1.20  0.57 9.87% 
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hsa-miR-92b 1.18  0.13 7.09% 
hsa-miR-125b 1.15  0.69 11.17% 
hsa-miR-4741 1.13  0.06 7.58% 
hsa-miR-3195 1.07  0.67 8.27% 
hsa-miR-22 1.06  -0.66 11.26% 
hsa-miR-4259 1.04  0.13 6.87% 
hsa-miR-296-3p 1.03  -0.48 9.87% 
hsa-miR-572 1.02  -0.64 6.97% 
hsa-miR-3125 1.02  0.23 10.27% 
hsa-miR-1237 1.02  0.22 4.61% 
hsa-miR-5095 1.01  -0.79 9.89% 
hsa-miR-518a-3p 1.01  -0.53 9.59% 
hsa-miR-518d-3p 1.01  -0.53 15.32% 
hsa-miR-3939 1.00  0.49 6.54% 
hsa-miR-4497 -7.69§  -0.88 8.22% 
hsa-miR-4508 -2.86§  -0.81 10.85% 
hsa-miR-378c -2.63§  0.07 17.86% 
hsa-miR-378 -2.44§  0.00 18.44% 
hsa-miR-658 -2.27§  -0.83 9.43% 
hsa-miR-320a -2.04§  -0.21 12.15% 
hsa-miR-451 -2.04§  0.53 16.59% 
hsa-miR-320b -2.04§  -0.13 9.99% 
hsa-miR-100 -1.82  0.39 12.84% 
hsa-miR-636 -1.79  -0.97 9.82% 
hsa-miR-3665 -1.69  -0.98 15.55% 
hsa-miR-4532 -1.61  -0.78 14.67% 
hsa-miR-1224 -1.61  -0.71 13.43% 
hsa-miR-639 -1.56  -0.89 10.98% 
hsa-miR-432 -1.45  0.17 8.56% 
hsa-miR-657 -1.43  -0.01 8.36% 
hsa-miR-9 -1.43  0.37 6.93% 
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hsa-miR-4674 -1.39  -0.73 8.47% 
hsa-miR-4488 -1.39  -0.59 13.41% 
hsa-miR-128 -1.32  0.47 8.35% 
hsa-miR-3196 -1.23  -0.78 10.53% 
hsa-miR-3178 -1.20  -0.12 7.57% 
hsa-miR-4463 -1.20  0.23 7.34% 
hsa-miR-3653 -1.20  0.28 8.29% 
hsa-miR-1908 -1.20  0.34 7.83% 
hsa-miR-184 -1.19  0.98 6.62% 
hsa-miR-662 -1.18  -0.70 6.57% 
hsa-miR-4660 -1.16  0.81 8.54% 
hsa-miR-4784 -1.15  0.66 6.63% 
hsa-miR-3972 -1.12  0.44 7.59% 
hsa-miR-26a -1.11  0.46 7.97% 
hsa-miR-1231 -1.10  -0.31 9.21% 
hsa-miR-1289-2 -1.09  -0.22 8.56% 
hsa-miR-2110 -1.05  0.47 9.56% 
hsa-miR-627 -1.04  0.52 5.53% 
hsa-miR-103a-2 -1.03  0.72 7.01% 
hsa-miR-103b-2 -1.03  0.72 7.02% 
hsa-miR-935 -1.02  0.55 9.39% 
hsa-miR-3615 10.20¶  0.17 36.26% 
hsa-miR-760 9.16¶  -0.14 36.44% 
hsa-miR-944 8.82¶  -0.19 37.44% 
hsa-miR-617 8.35¶  -0.34 38.02% 
hsa-miR-411 7.45¶  -0.27 37.50% 
hsa-miR-212 6.45¶  0.43 36.05% 
hsa-miR-3925-5p 6.35¶  0.44 >100% 
hsa-miR-3180-4 6.17¶  -0.04 35.78% 
hsa-miR-3940 5.97¶  0.58 36.65% 
hsa-miR-26a-1 5.93¶  0.32 36.92% 
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hsa-miR-665 5.38¶ 0.38 36.84% 
hsa-miR-3619 5.37¶ 0.35 36.97% 
hsa-miR-1247 5.11¶ -0.09 36.32% 
hsa-miR-4785 4.96¶ 0.13 35.81% 
hsa-miR-4767 4.94¶ 0.08 36.43% 
hsa-miR-765 4.68¶ 0.57 36.34% 
hsa-miR-4459 4.65¶ 0.09 36.54% 
hsa-miR-1249 4.38¶ 0.56 36.08% 
hsa-miR-4313 4.03¶ -0.16 36.20% 
hsa-miR-99a 3.95¶ 0.28 36.62% 
hsa-miR-1273e 3.02¶ 0.60 36.48% 
hsa-miR-4538 3.01¶ 0.06 36.28% 
hsa-miR-4492 -16.67§ -0.06 38.46% 
hsa-miR-3941 -7.69§ 0.05 36.38% 
hsa-miR-3656 -7.14§ -0.03 36.31% 
hsa-miR-143 -6.25§ 0.14 37.27% 
hsa-miR-3168 -6.25§ -0.16 36.29% 
hsa-miR-7 -5.88§ 0.27 37.75% 
hsa-miR-920 -5.56§ -0.17 35.95% 
hsa-miR-4285 -4.76§ 0.10 36.27% 
hsa-miR-326 -4.35§ 0.14 35.98% 
hsa-miR-551a -4.00§ 0.21 36.46% 
hsa-miR-584 -3.85§ -0.03 36.00% 
hsa-miR-483-5p -3.23§ 0.23 36.80% 
hsa-miR-4458 -2.94§ 0.08 36.25% 
hsa-miR-4754 -2.86§ -0.04 36.12% 
hsa-miR-197 -2.44§ 0.03 36.25% 
hsa-miR-4449 -1.35 -0.56 37.78% 
hsa-miR-320e 27.86¶ 0.26 54.38% 
hsa-miR-638 25.33¶ 0.22 54.10% 
hsa-miR-4258 22.09¶ 0.13 53.61% 
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hsa-miR-526a-1 19.49¶ -0.04 53.70% 
hsa-miR-3916 5.19¶ 0.31 55.00% 
hsa-miR-3545 4.93¶ -0.12 53.75% 
hsa-miR-4778-5p 3.27¶ 0.28 58.40% 
hsa-miR-549 3.24¶ -0.25 56.73% 
hsa-miR-4453 3.05¶ 0.15 54.31% 
hsa-miR-1302-5 2.25¶ -0.51 54.87% 
hsa-miR-647 1.82 -0.16 53.93% 
hsa-miR-4329 1.78 0.05 54.78% 
hsa-miR-4484 1.57 -0.08 54.01% 
hsa-miR-936 1.48 -0.58 55.91% 
hsa-miR-4283-1 1.46 -0.32 54.00% 
hsa-miR-4283-2 1.46 -0.32 54.00% 
hsa-miR-4763 1.40 0.03 54.15% 
hsa-miR-484 1.31 0.18 54.32% 
hsa-miR-4308 1.29 -0.02 53.60% 
hsa-miR-182 1.27 -0.07 53.75% 
hsa-miR-4632 1.25 -0.31 53.67% 
hsa-miR-518e* 1.21 -0.30 54.15% 
hsa-miR-519a* 1.21 -0.30 54.15% 
hsa-miR-519b-5p 1.21 -0.30 57.44% 
hsa-miR-519c-5p 1.21 -0.30 57.44% 
hsa-miR-522* 1.21 -0.30 54.15% 
hsa-miR-523* 1.21 -0.30 54.15% 
hsa-miR-1181 1.18 0.21 53.87% 
hsa-miR-1250 1.18 -0.39 54.52% 
hsa-miR-4535 1.15 -0.49 53.57% 
hsa-miR-448 1.15 -0.31 54.23% 
hsa-miR-525-3p 1.10 -0.34 54.27% 
hsa-miR-524-3p 1.09 -0.34 54.26% 
hsa-miR-4311 1.06 0.23 54.43% 
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hsa-miR-1273d 1.04 0.05 54.13% 
hsa-miR-519a-2 1.04 0.01 53.70% 
hsa-miR-1827 1.02 0.03 54.44% 
hsa-miR-135b -33.33§ -0.12 53.67% 
hsa-miR-4707-3p -25.00§ -0.18 >100% 
hsa-miR-761 -20.00§ -0.19 54.01% 
hsa-miR-27a -16.67§ -0.13 54.01% 
hsa-miR-524 -5.88§ -0.13 53.96% 
hsa-miR-219-1 -4.55§ -0.39 54.04% 
hsa-miR-378d -2.33§ -0.25 56.01% 
hsa-miR-1254 -1.96 -0.09 53.98% 
hsa-miR-27b -1.35 0.97 54.69% 
hsa-let-7a -1.22 -0.19 54.49% 
hsa-miR-193a -1.16 -0.19 53.77% 
hsa-miR-29a -1.08 1.00 54.01% 
hsa-miR-200b -1.03 -0.19 54.41% 
hsa-miR-298 -1.02 -0.10 54.51% 
Abbreviation: ICC: Intraclass correlation coefficient; CV: variation of coefficient. 
†Fold change of plasma miRNAs presented in at least 70% samples was the ratio of log2 transformed normalized read counts of 
deceased twins to their co-twin brothers alive. ¶over-expressed (increased concentration) miRNA with a fold change ≥ 2; §under-
expressed (decreased concentration) miRNA with a fold change ≤-2.   
‡ICCs of plasma miRNAs present in at least 70% samples from co-twins in twin pairs. 
Note: the bold miRNAs were mentioned in the discussion. 
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Table 3   Top 20 plasma miRNAs with the smallest p-value* 
 
*The comparison of the log 2 transformed normalized miRNA levels between long-lived and short-lived co-twins were performed using paired t-test 
from the 167 present in at least 70% of samples and 699 miRNAs that were present in less than 70% of samples (i.e. non-present miRNAs).  
†mean (SD)
miRNAs (present at least 70%)   miRNAs (present less than 70%) 
miRNA ID Short-lived 
co-twins† 
Long-lived 
co-twins† 
P miRNA ID Short-lived co-
twins† 
Long-lived 
co-twins† 
P 
hsa-miR-3615 10.52(0.8) 9.51(0.47) 0.02 hsa-miR-423-5p 2.25(4.5) 9.74(1.19) 0.03 
hsa-miR-619 11.49(1) 10.68(0.8) 0.04 hsa-miR-4305 2.26(4.52) 9.72(0.28) 0.04 
hsa-miR-4419a 10.96(0.85) 10.34(1.22) 0.09 hsa-miR-661 0(0) 6.53(4.35) 0.06 
hsa-miR-1273e 9.2(0.59) 9.86(1.05) 0.09 hsa-miR-1273c 6.73(4.49) 0(0) 0.06 
hsa-miR-135b 4.98(5.75) 10.08(0.41) 0.15 hsa-miR-192 0(0) 6.54(4.36) 0.06 
hsa-miR-2861 10.33(0.93) 9.45(0.28) 0.17 hsa-miR-4764-5p 0(0) 6.59(4.4) 0.06 
hsa-miR-184 9.71(0.66) 9.61(0.78) 0.20 hsa-miR-4303 6.78(4.53) 0(0) 0.06 
hsa-miR-370 10.57(1.24) 10.35(1.18) 0.20 hsa-miR-4288 6.93(4.65) 0(0) 0.06 
hsa-miR-3648 11.09(0.77) 10.32(0.55) 0.21 hsa-miR-4721 2.35(4.71) 9.29(1) 0.07 
hsa-miR-1254 6.56(4.37) 9.93(0.33) 0.21 hsa-miR-3609 2.16(4.33) 7.47(5.08) 0.11 
hsa-miR-761 5.11(5.9) 9.88(0.69) 0.21 hsa-miR-4647 4.37(5.05) 9.34(0.43) 0.14 
hsa-miR-4707-3p 4.9(5.67) 9.39(0.4) 0.22 hsa-miR-93 4.94(5.71) 10.02(0.87) 0.15 
hsa-miR-1249 9.89(0.83) 10.37(0.65) 0.23 hsa-let-7g 2.99(5.99) 9.05(0.65) 0.15 
hsa-miR-4306 11.68(1.18) 10.73(0.53) 0.26 hsa-miR-641 7.5(5.12) 2.56(5.11) 0.15 
hsa-miR-4660 11.19(1.08) 11.56(0.88) 0.27 hsa-miR-194-2 4.59(5.32) 9.25(0.35) 0.16 
hsa-miR-212 10.04(0.75) 9.57(0.65) 0.27 hsa-miR-1470 7.27(4.91) 2.14(4.27) 0.16 
hsa-miR-3941 7.55(5.08) 10.75(0.81) 0.27 hsa-miR-1238 2.24(4.49) 7.04(4.7) 0.16 
hsa-miR-665 10.57(1.47) 7.89(5.32) 0.28 hsa-miR-127 2.34(4.68) 7.12(4.75) 0.17 
hsa-miR-27a 5.1(5.91) 9.01(0.19) 0.29 hsa-miR-485 7.43(5.05) 2.54(5.08) 0.17 
hsa-miR-3168 7.41(4.98) 10.63(0.46) 0.31  hsa-miR-1283-2 7.2(4.88) 2.65(5.31) 0.17 
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Figure 1. Age at death or age at the last follow-up date (years) in four monozygotic twin pairs 
Solid symbol: deceased; Hollow symbol: alive 
The number below the horizontal bar inside the figure indicated minimum differences in the life 
expectancy in years between deceased twins and their alive co-twin brothers  
Pair ID: 1: P0005; 2: P0004; 3: P0003; 4: P0002
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Figure 2  The Number of miRNA presented in the plasma from nine monozygotic twins 
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Figure 3. Boxplot of the five most abundant miRNAs 
Differential expression of the five most abundantly expressed miRNAs in our monozygotic twins. The total numbers of 
miRNA reads are log2 transformed.  
The length of the box represents the interquartile range (the distance between the 25th and 75th percentiles). 
◊ The symbol inside the box represents the group mean.
The horizontal line inside the box represents the group median. 
The vertical lines from the box extend to the group minimum and maximum values. 
